Y-mAbs Therapeutics, Inc. Quarterly Operating Lease, Liability, Current in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
Y-mAbs Therapeutics, Inc. quarterly Operating Lease, Liability, Current history and growth rate from Q1 2019 to Q3 2024.
  • Y-mAbs Therapeutics, Inc. Operating Lease, Liability, Current for the quarter ending September 30, 2024 was $776K, a 13.6% decline year-over-year.
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $776K -$122K -13.6% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $842K +$13K +1.57% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $888K +$33K +3.86% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $902K +$34K +3.92% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 $898K -$302K -25.2% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $829K -$263K -24.1% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $855K -$596K -41.1% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $868K -$915K -51.3% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $1.2M -$649K -35.1% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $1.09M -$922K -45.8% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $1.45M -$520K -26.4% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $1.78M -$183K -9.31% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $1.85M -$38K -2.01% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $2.01M +$1.45M +254% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $1.97M +$1.42M +260% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $1.97M +$1.45M +281% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $1.89M +$1.37M +266% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $569K +$67K +13.3% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $548K +$31K +6% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $516K Dec 31, 2019 10-K 2021-03-01
Q3 2019 $516K Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $502K Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $517K Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.